No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HLN240816C7500
- 1.46
- +0.06+4.29%
15min DelayClose Jul 22 16:00 ET
1.60High1.46Low
1.60Open1.40Pre Close11 Volume241 Open Interest7.50Strike Price1.62KTurnover45.31%IV0.45%PremiumAug 16, 2024Expiry Date1.42Intrinsic Value100Multiplier24DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.9402Delta0.1127Gamma6.05Leverage Ratio-0.0035Theta0.0047Rho5.69Eff Leverage0.0028Vega
Intraday
- 5D
- Daily
News
U.S. Pediatric Supplements Market Insights 2024-2029 Featuring Key Vendors - Abbott, Amway, Haleon, Bayer, Reckitt Benckiser, Nestle, Sanofi-aventis, Unilever, THG, H&H - ResearchAndMarkets.com
Morgan Stanley Maintains Haleon(HLN.US) With Buy Rating, Raises Target Price to $9.45
Haleon PLC (HLN) Gets a Buy From Barclays
Express News | Haleon PLC : Morgan Stanley Raises Target Price to $9.45 From $9.3
Small, Mid-size Biotechs Could See M&A Action in H2 - PwC
United Kingdom Oral Care Market Forecast and Opportunities to 2029, Featuring Procter & Gamble, GlaxoSmithKline, Colgate, Unilever, Spotlight Oral Care, Haleon and Oral Care Innovations
Comments
$Haleon(HLN.US$ COVID on the rise again...Haleon's Panadol will b flying off the shelves again as it offers the best flu symptoms relief.
$SIA(C6L.SG$ $HKEX(00388.HK$ $DBS Group Holdings(D05.SG$ $OCBC Bank(O39.SG$ $SATS(S58.SG$ $Olam Group(VC2.SG$ $CapitaLandInvest(9CI.SG$ $CapLand Ascott Trust(HMN.SG$ $Sheng Siong(OV8.SG$ $Top Glove(BVA.SG$ $Singtel 10(Z77.SG$ $ParkwayLife Reit(C2PU.SG$ $Novo-Nordisk A/S(NVO.US$ $Grab Holdings(GRAB.US$
$SIA(C6L.SG$ $HKEX(00388.HK$ $DBS Group Holdings(D05.SG$ $OCBC Bank(O39.SG$ $SATS(S58.SG$ $Olam Group(VC2.SG$ $CapitaLandInvest(9CI.SG$ $CapLand Ascott Trust(HMN.SG$ $Sheng Siong(OV8.SG$ $Top Glove(BVA.SG$ $Singtel 10(Z77.SG$ $ParkwayLife Reit(C2PU.SG$ $Novo-Nordisk A/S(NVO.US$ $Grab Holdings(GRAB.US$
1
3
$Haleon(HLN.US$ Can someone please let me know why this is way cheaper than the Haleon PLC listed on LSE?
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Encompass Health(EHC.US$ - up 8.0%
2. $KT Corp(KT.US$ - up 1.9%
3. $Haleon(HLN.US$ - up 1.7%
4. $ServiceNow(NOW.US$ - up 1.3%
5. $Elbit Systems(ESLT.US$ - up 0.8%
6. $Check Point Software(CHKP.US$ - up 0.4%
7. $GlaxoSmithKline(GSK.US$ - up 0.4%
8. $Diageo(DEO.US$ - u...
Gap Ups
1. $Encompass Health(EHC.US$ - up 8.0%
2. $KT Corp(KT.US$ - up 1.9%
3. $Haleon(HLN.US$ - up 1.7%
4. $ServiceNow(NOW.US$ - up 1.3%
5. $Elbit Systems(ESLT.US$ - up 0.8%
6. $Check Point Software(CHKP.US$ - up 0.4%
7. $GlaxoSmithKline(GSK.US$ - up 0.4%
8. $Diageo(DEO.US$ - u...
+11
9
1
$Haleon(HLN.US$ buy sell or hold? Exceeded my expectations too soon. Perplexed.
$Sheng Siong(OV8.SG$ $Food Empire(F03.SG$ $Olam Group(VC2.SG$ $Wilmar Intl(F34.SG$ $ComfortDelGro(C52.SG$ $GlaxoSmithKline(GSK.US$ $UBS Group(UBS.US$ $Unilever(UL.US$
$Sheng Siong(OV8.SG$ $Food Empire(F03.SG$ $Olam Group(VC2.SG$ $Wilmar Intl(F34.SG$ $ComfortDelGro(C52.SG$ $GlaxoSmithKline(GSK.US$ $UBS Group(UBS.US$ $Unilever(UL.US$
3
1
Read more